Set as featured image for the article explaining handling of disease progression as an adverse event
Exploring Adverse Events

Disease Progression: A Special Case of Adverse Events

This article explores the concept of disease progression in pharmacovigilance, highlighting its distinction from other adverse events like Loss of Efficacy (LOE). It explains how disease progression reports can be handled.

Bala
Read
Set as featured image for the blog where we explains about handling the reports that you may face of no adverse events
Exploring Adverse Events

No Adverse Event: A Comprehensive Overview

This comprehensive blog provides an in-depth look at what no adverse event reports are, while also addressing the uncertainties and scenarios you may encounter when handling these reports.

Bala
Read
Set as featured image made from inkscape for the blog where we explains about choosing and managing master cases in controlling duplicates
ICSR Management

Master Cases in ICSR Management

In this blog, we take a deep dive into ICSR management, focusing on an important aspect: managing duplicates. This time, we explore the process of selecting a master case for merging duplicate cases effectively.

Bala
Read
Set as featured image for the article where we explains about criteria and conventions in handling adverse events as primarily as serious adverse events
ICSR Management

Serious Adverse Events: Criteria and Guidelines

This blog explores how to effectively handle significant events, focusing on what qualifies as a “serious” event and the process of upgrading or downgrading events as they unfold. Understanding the severity of an event allows for a more adaptive and responsive approach to event management.

Bala
Read

Copyright © Drugvigil. All Rights Reserved.